Financials
- Market Capitalization 8.4 B
- Employee 261
- Founded 2022
- CEO N/A
- Website www.apogeetherapeutics.com
- Headquarter California, United States
- FIGI BBG01H51WYQ5
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1013 | IBRX ImmunityBio, Inc. - Common Stock | 8.05 USD | -4.17% | +4.82% | +11.50% | +244.02% | 8.53 B USD | ||
| 1014 | IMVT Immunovant, Inc. - Common Stock | 41.20 USD | -5.98% | -6.36% | +6.71% | +114.47% | 8.51 B USD | ||
| 1040 | TGTX TG Therapeutics, Inc. - Common Stock | 53.93 USD | -3.21% | +1.39% | +0.88% | +83.62% | 8.26 B USD | ||
| 1057 | SYRE Spyre Therapeutics, Inc. - Common Stock | 90.36 USD | -3.48% | -15.15% | -8.04% | +277.92% | 7.97 B USD |